Complete Genomics and Velsera are collaborating to deliver an end-to-end genetic testing solution that integrates DNBSEQ™ sequencing technology with Velsera’s Clinical Genomics Workspace (CGW) data ...
Complete Genomics, a U.S.-based leader in genomic sequencing technologies, today announced results demonstrating that AI-trained variant calling models can reduce genome analysis errors by up to 73% ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. It's been a long, long time since one of OVP Venture ...
BOSTON, Nov. 11, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS (SOPH) (NASDAQ: SOPH), a global leader in ...
BOSTON, Nov. 11, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS (SOPH) (Nasdaq: SOPH), a global leader in ...
The DNBSEQ-T1+ is a next-generation mid-throughput sequencer that completes a paired end 150 sequencing workflow in just 24 hours with Q40 accuracy. With three flow cell formats, two to four ...
Complete Genomics is a pioneering life sciences company that provides novel, end to end DNA sequencing solutions. It has been at the forefront of high throughput sequencing technology development ...
Explore the decades-long journey to map the full human genome, from early breakthroughs to the first complete, gapless DNA sequence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results